T Klaukka

Author PubWeight™ 75.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997 9.63
2 Resistance to erythromycin in group A streptococci. N Engl J Med 1992 4.42
3 Asthma programme in Finland: a community problem needs community solutions. Thorax 2001 2.68
4 Reliability and validity of interview data on chronic diseases. The Mini-Finland Health Survey. J Clin Epidemiol 1993 2.22
5 A 10 year asthma programme in Finland: major change for the better. Thorax 2006 2.13
6 Incidence of occupational asthma and persistent asthma in young adults has increased in Finland. Chest 1996 1.61
7 Rheumatic symptoms in the middle-aged population in southwestern Finland. Scand J Rheumatol Suppl 1982 1.55
8 Acute childhood asthma in Finland: a retrospective review of hospital admissions from 1976 to 1995. Pediatr Allergy Immunol 2000 1.50
9 Work is related to a substantial portion of adult-onset asthma incidence in the Finnish population. Am J Respir Crit Care Med 2001 1.47
10 Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995 1.43
11 Reliability of perceived health by sex and age. Soc Sci Med 1999 1.43
12 Triazolam and violent deaths. Lancet 1992 1.39
13 Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis 1995 1.22
14 Epidemiology of rheumatoid arthritis in Finland. Semin Arthritis Rheum 1998 1.20
15 Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis 2001 1.19
16 Excess incidence of asthma among Finnish cleaners employed in different industries. Eur Respir J 2002 1.12
17 Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population. Eur J Clin Pharmacol 2000 1.10
18 Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals. Diabetes Care 2000 1.03
19 The IL1A genotype is associated with nasal polyposis in asthmatic adults. Allergy 2003 1.01
20 Fatal poisonings with antidepressants in Finland 1985-1987. Acta Psychiatr Scand Suppl 1989 0.99
21 Recent trends in the consumption of lipid-lowering drugs in Finland. J Clin Epidemiol 1996 0.98
22 Antibiotic use by indication: a basis for active antibiotic policy in the community. Scand J Infect Dis 2001 0.97
23 Epidemiology of rheumatic diseases in Finland in 1964-76. Scand J Rheumatol Suppl 1982 0.97
24 Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clin Exp Allergy 2003 0.96
25 A model to classify the sedative load of drugs. Int J Geriatr Psychiatry 2003 0.96
26 Psychotropics among the home-dwelling elderly--increasing trends. Int J Geriatr Psychiatry 2002 0.96
27 Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women. J Epidemiol Community Health 1991 0.95
28 Indication-based use of antimicrobials in Finnish primary health care. Description of a method for data collection and results of its application. Scand J Prim Health Care 1999 0.95
29 Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987. Am J Epidemiol 1991 0.95
30 Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions. J Allergy Clin Immunol 1999 0.94
31 Antidepressants and suicide mortality. J Affect Disord 1998 0.94
32 The relationship between erythromycin consumption and resistance in Finland. Finnish Study Group for Antimicrobial Resistance. Ciba Found Symp 1997 0.92
33 The effectiveness of vocationally oriented multidisciplinary intervention on sickness absence and early retirement among employees at risk: an observational study. Occup Environ Med 2009 0.91
34 Prevalence of work-aggravated symptoms in clinically established asthma. Eur Respir J 2003 0.89
35 Use of psychotropic drugs in Finland. Soc Sci Med 1984 0.89
36 Use of antimicrobials and risk of type 1 diabetes in a population-based mother-child cohort. Diabetologia 2005 0.88
37 Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels. Diabetologia 2006 0.88
38 Erythromycin resistance of group A streptococci from throat samples is related to age. Pediatr Infect Dis J 1997 0.87
39 Back pain and arthrosis in Finland. How many patients by the year 2000? Acta Orthop Scand Suppl 1991 0.86
40 Consumption of analgesics and anti-inflammatory drugs in the nordic countries between 1978-1988. Eur J Clin Pharmacol 1991 0.86
41 Rheumatic disorders in the Finnish health care system in 1964-1976. Scand J Rheumatol Suppl 1982 0.85
42 Use of vitamin supplements in Finland. Eur J Clin Pharmacol 1985 0.84
43 Methotrexate is the leading DMARD in Finland. Ann Rheum Dis 2003 0.84
44 Corticosteroid therapy and need for hospital care in wheezing preschool children. Eur J Clin Pharmacol 2000 0.83
45 Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance. Allergy 2009 0.83
46 Is physiotherapy effective for musculoskeletal disorders? Scand J Rheumatol Suppl 1987 0.82
47 Reasons for and costs of hospitalization for pediatric asthma: a prospective 1-year follow-up in a population-based setting. Pediatr Allergy Immunol 2001 0.81
48 The asthma programme of Finland: an evaluation survey in primary health care. Int J Tuberc Lung Dis 2003 0.81
49 Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma. Respir Med 2001 0.80
50 Hospitalization trends for paediatric asthma in eastern Finland: a 10-yr survey. Eur Respir J 2002 0.80
51 Adoption of celecoxib and rofecoxib: a nationwide database study. J Clin Pharm Ther 2005 0.79
52 Antimicrobial resistance of fecal aerobic gram-negative bacilli in different age groups in a community. Antimicrob Agents Chemother 1996 0.79
53 Mechanical ventilation in children with severe asthma. Pediatr Pulmonol 2001 0.79
54 Decline in the incidence of renal failure due to amyloidosis associated with inflammatory rheumatic diseases. Amyloid 2011 0.79
55 Validation of a questionnaire on cow's milk allergy: parental reports and physician's diagnosis. Acta Paediatr 2010 0.77
56 Effects of multidisciplinary inpatient rehabilitation for chronic back or neck pain: a register-linkage study of sickness absences and analgesic purchases in an occupational cohort. Occup Environ Med 2007 0.77
57 Prescription of antimicrobial agents to elderly people in relation to the type of infection. Age Ageing 1997 0.77
58 Societal and health care benefits of early use of inhaled steroids. Thorax 1998 0.76
59 Psychotropic drugs: long-term use, dependency and the gender factor. Soc Sci Med 1994 0.76
60 Antidepressants and suicide. BMJ 1994 0.75
61 Cow's milk allergy in children: adherence to a therapeutic elimination diet and reintroduction of milk into the diet. Eur J Clin Nutr 2010 0.75
62 The association between team climate at work and mental health in the Finnish Health 2000 Study. Occup Environ Med 2009 0.75
63 [Health education in Finland: insufficient co-operation]. Nord Med 1973 0.75
64 [Can imipramine-chlorpyramine be teratogenic?]. Katilolehti 1973 0.75
65 [Asthma deaths and asthma medication consumption in Finland]. Duodecim 1997 0.75
66 Who is using antihypertensive drugs? A prescription analysis from Finland. Scand J Prim Health Care 1996 0.75
67 Communicating with patients about their medications. N Engl J Med 1992 0.75
68 Application of the O.E.C.D. disability questions in Finland. Rev Epidemiol Sante Publique 1981 0.75
69 Leaflets reinforce counseling. Am Pharm 1992 0.75
70 [What can we do to prevent backache?]. Duodecim 1985 0.75
71 [Asthma mortality and utilization of antiasthmatic agents in Finland]. Duodecim 1996 0.75
72 Does beta-blockade provoke intermittent claudication? Acta Med Scand 1985 0.75
73 [Why is the consumption of hypnotics higher in Denmark than in Finland?]. Nord Med 1985 0.75
74 [Do we use health services efficiently?]. Duodecim 1985 0.75
75 Health care development in Finland, 1960 to 2010. World Health Forum 1992 0.75
76 Do inhaled steroids differ from cromones in terms of hospital admission rates for asthma in children? Acta Paediatr 2004 0.75
77 [The effectiveness of research on the treatment of refractory axial and locomotor disorders]. Duodecim 1989 0.75
78 Smoking makes asthma expensive: a register-based study in Finland. Int J Tuberc Lung Dis 2007 0.75
79 [Leisure time physical examination by public health nurses]. Sairaanhoitaja 1976 0.75